The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment Program has posted a draft systematic review for review. This draft is entitled “Definition of Treatment-Resistant Depression in the Medicare Population”. If you are interested in reviewing this document, please visit: http://www.ahrq.gov/research/ findings/ta/index.html. The document will be available for review from 9:00 am on SEPTEMBER 1, 2017 to 5:00 pm on SEPTEMBER 22, 2017. If you have any questions, please contact ahrqtap@ahrq.hhs.gov.
Available for Public Comment
Definition of Treatment-Resistant Depression in the Medicare Population
Draft for Review Open: Sept. 1 - 22
Draft for Review Open: Sept. 1 - 22
Topics seeking supplemental evidence and data
None at this time
Technology Assessment Program
The Technology Assessment (TA) Program at the Agency for Healthcare Research and Quality (AHRQ) provides technology assessments for the Centers for Medicare & Medicaid Services (CMS). These technology assessments are used by CMS to inform its national coverage decisions for the Medicare program as well as provide information to Medicare carriers.
- Public Review
- Technology Assessments Completed
- Technology Assessments in Progress
- Technical Briefs In Progress
- Topic Refinements Completed
- Topic Refinements in Progress
- Technology Assessment Archive
AHRQ's TA Program uses state-of-the-art methodologies for assessing the clinical utility of medical interventions. Technology assessments are based on a systematic review of the literature, along with appropriate qualitative and quantitative methods of synthesizing data from multiple studies.
Technology assessments are conducted by our Evidence-based Practice Center Program or may be done in house by AHRQ staff. For additional information on the EPC reports conducted for the Technology Assessment Program, please contact epc@ahrq.hhs.gov.
Potential TA topics may go through a formal AHRQ Topic Refinement process. When CMS requests a Topic Refinement, the potential TA’s key questions and overall scope are reviewed by invited stakeholders, and the resulting document is posted for public comment.
Public Review
Draft reports available for public comment
- Definition of Treatment-Resistant Depression in the Medicare Population [Protocol PDF—464 KB (Amended March 2017)]
To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the CMS Medicare Coverage and AHRQ Effective Health Care Email distribution lists 1 week before the posting of draft reports. Each report will be available for public review on this Web site for a total of 3 weeks.
The AHRQ TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program Web site within 3 months after the associated final report is posted on this Web site. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.
If topics undergo a formal Topic Refinement, the Topic Refinement document containing the scope of the potential TA will be posted on the AHRQ TA Web site for 2 weeks for public comment. Once public comments have been considered and revisions have been completed, the final Topic Refinement document will be posted on the AHRQ Web site.
Technology Assessments Completed
2016
- Retinal Prostheses in the Medicare Population
Protocol PDF - 216.32 KB
Disposition of Comments PDF - 500.16 KB - Renal Denervation in the Medicare Population
Protocol PDF - 98.37 KB
Disposition of Comments PDF - 1.23 MB
2015
- Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee
Disposition of Comments PDF - 660.61 KB - Cardiovascular Procedures and Subsequent Cognitive Function
Disposition of Comments PDF - 153.98 KB - Catheter Ablation for Atrial Fibrillation
Disposition of Comments PDF - 576.44 KB - Pain Management Injection Therapies for Low Back Pain
Disposition of Comments PDF - 621.67 KB - Use of Cardiac Resynchronization Therapy in the Medicare Population
Disposition of Comments PDF - 335.78 KB
2014
- Molecular Pathology Testing for the Estimation of Prognosis for Common Cancers
Disposition of Comments PDF - 1.93 MB - Negative Pressure Wound Therapy Technologies for Chronic Wound Care in the Home Setting
Disposition of Comments
2013
- Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death
Disposition of Comments [PDF—722 KB] - Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer
Disposition of Comments - Skin Substitutes for Treating Chronic Wounds: Final Report [PDF—1.4 MB]
Disposition of Comments PDF—1.89 MB] - Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin
Disposition of Comments [PDF—520 KB] - Update on Genetic Tests Currently Available for Clinical Use in Common Cancers
Disposition of Comments [PDF—292 KB]
2012
- The Impact of Pre-transplant Red Blood Cell Transfusions in Renal Allograph Rejection
Disposition of Comments - Management of Asymptomatic Carotid Stenosis [PDF—1.7 MB]
Disposition of Comments - Measuring Health-Related Quality of Life for Patients with Diabetic Retinopathy
Disposition of Comments - Systematic Review of Decision Tools and their Suitability for Patient-Centered Decisionmaking regarding Electronic Cardiac Device
- Systematic Review of ECG-based Signal Analysis Technologies for Evaluating Patients With Acute Coronary Syndrome
Disposition of Comments - Update on Mapping the Landscape of Genetic Tests for Non-Cancer Diseases/Conditions
Disposition of Comments
2011
- Effectiveness of Cochlear Implants in Adults with Sensorineural Hearing Loss
Disposition of Comments - Health Risk Appraisal
Disposition of Comments - Lifestyle Interventions for Four Conditions: Breast Cancer, Prostate Cancer, Type 2 Diabetes Mellitus, and Metabolic Syndrome
Disposition of Comments - Outcomes of Sipuleucel-T Therapy
Disposition of Comments - Update of Horizon Scans of Genetic Tests Currently Available for Clinical Use in Cancers
Disposition of Comments
* Not available electronically. Contact epc@ahrq.hhs.gov for report availability.
** Report is completed, but in the process of being prepared for posting. Please check back for updates.
Technology Assessment Program Products in Progress
Reports in late-production phase (post-review):
- Short and Long Term Outcomes after Bariatric Therapies in the Medicare Population [Protocol PDF —372 KB]
- Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD) [Protocol PDF—392.95 KB]
Draft reports available for public comment
- Definition of Treatment-Resistant Depression in the Medicare Population [Protocol PDF—464 KB (Amended March 2017)]
Key Questions available for public comment
Topics seeking supplemental evidence and data
None at this time
Additional information for technology assessments can be submitted for the topics listed above. Details and submission instructions can be found here.
Topic Refinements Completed
- Catheter Ablation for Atrial Fibrillation [PDF—216 KB]
- Pain Management Injection Therapies for Low-Back Pain [PDF—77 KB]
- Therapeutic Options for Obesity in the Medicare Population [PDF—316 KB]
- Use of Cardiac Resynchronization Therapy in the Medicare Population [PDF—142 KB]
Topic Refinements in Progress
Topic refinements in early production phase (pre-review)
- Home Mechanical Ventilators.
Technology Assessment Archive
Technology Assessments for 1990-2010
These technology assessments were completed at least 4 years ago, and some as many as 20 years ago. These assessments may be outdated due to more recent research findings not included in the assessments and should be viewed cautiously in current medical practice. They are maintained for archival purposes only.
These technology assessments were completed at least 4 years ago, and some as many as 20 years ago. These assessments may be outdated due to more recent research findings not included in the assessments and should be viewed cautiously in current medical practice. They are maintained for archival purposes only.
Page last reviewed September 2017
Page originally created January 2013
Page originally created January 2013
Internet Citation: Technology Assessment Program. Content last reviewed September 2017. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/ta/index.html
No hay comentarios:
Publicar un comentario